Denice Torres

Ms. Denice M.
Torres is an Independent Director at Celldex Therapeutics, Inc., an Independent Director at Seaport Therapeutics, Inc., an Independent Director at Glaukos Corp., a Chief Executive Officer at Ignited LLC and a Member at State Bar of Michigan.
She is on the Board of Directors at Celldex Therapeutics, Inc., Seaport Therapeutics, Inc., ByHeart, Inc., Glaukos Corp., National Resilience, Inc. and Wylei, Inc. Ms. Torres was previously employed as a Lead Independent Director by 2seventy Bio, Inc., a Chairman by Surface Oncology, Inc., an Independent Director by Karuna Therapeutics, Inc., an Independent Director by bluebird bio, Inc., a Founder by The Mentoring Place, a President by ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC., a Chief Strategy & Transformation Officer by Johnson & Johnson, and an Executive Director-Global Neuroscience by Eli Lilly & Co. She also served on the board at Thirty Madison, Inc., NeuroScience, Inc. and OWHealth, Inc. She received her undergraduate degree from Ball State University (Indiana), a graduate degree from Centenary University, a graduate degree from Indiana University Maurer School of Law and an MBA from the University of Michigan.